Drugs & TargetsFree C2i Genomics and Ichilov bring cancer detection and monitoring platform to Israel August 11, 2023Vol.49 No.32
Drugs & Targets FDA approves Jemperli with chemotherapy for endometrial cancer August 04, 2023Vol.49 No.31
Drugs & Targets FDA approves Lonsurf with bevacizumab for previously treated metastatic colorectal cancer August 04, 2023Vol.49 No.31
Drugs & Targets Keytruda + trastuzumab + chemo receive positive CHMP opinion for first-line HER2+ gastric cancer July 28, 2023Vol.49 No.30
Drugs & Targets Opdivo receives positive CHMP opinion for early stage melanoma July 28, 2023Vol.49 No.30
Drugs & Targets MD Anderson, Nexo Therapeutics collaborate to advance therapies against intractable targets July 28, 2023Vol.49 No.30
Drugs & Targets FDA grants Ambrx Fast Track designation for prostate cancer ADC therapy July 21, 2023Vol.49 No.29
